Thomas Andrew Crockett - CEO, Director at KalVista Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Issuer Symbol
KALV on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Thomas Andrew Crockett since 12 Mar 2025

Holdings reported by Thomas Andrew Crockett for KalVista Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 211,203 $2,981,088 $14.11 20 Feb 2024 Direct
Performance Stock Units 62,500 $938,081 $15.01 17 Feb 2024 Direct Common Stock
Restricted Stock Unit 48,612 $729,632 $15.01 17 Feb 2024 Direct Common Stock
Performance Stock Unit 0 $8.23 17 Nov 2023 Direct Common Stock

Transactions reported by Thomas Andrew Crockett for KalVista Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.